Best in 7 days ANDA 080737 Cyanocobalamin Injection, USP 1,000 mcg/mL Applicant: American Regent, Inc. Module 1, Section 1.14.1.1 – Draft Car US$ 27.69 Sold : Login>>
PDF) Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants US$ 27.29 Min. order: 1 piece ★★★★★ 4.4 (258 reviews) Sold : Login>>
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 US$ 25.43 Min. order: 1 piece ★★★★★ 4.9 (151 reviews) Sold : Login>>
Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in an open-label head-to-head REDEFINE 4 trial in people with obesity, the primary endpoint was not achieved US$ 29.59 Min. order: 1 piece ★★★★★ 4.3 (184 reviews) Sold : Login>>
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial US$ 25.35 Min. order: 1 piece ★★★★★ 4.0 (66 reviews) Sold : Login>>
CagriSema, Novo Nordisk's Latest Obesity Drug Offering, Disappoints Investors with Trial Results US$ 21.74 Min. order: 1 piece ★★★★★ 4.9 (282 reviews) Sold : Login>>